Introduction
Cardiac catheterization is an invasive procedure that has evolved over the past 4 centuries. Although William Harvey's description of circulation was the cornerstone of cardiac hemodynamics, Stephen Hales is considered the pioneer of cardiac hemodynamics and cardiac catheterization, as he measured the first arterial pressure readings in the early 17th century.[1][2] The initial development of cardiac catheterization is based on animal experiments. Werner Forssmann performed the first human right cardiac catheterization in 1929.[3] Zimmermann HA performed the first left-sided cardiac catheterization in the 1950s.[4]
Cardiac catheterization underwent significant evolution in the 20th century, driven by the efforts of Andre Cournand, Dickinson Williams, and numerous other researchers.[5] After the initial work and development of cardiac catheterization, William Sones described the first selective coronary angiogram when he incidentally injected contrast in the right coronary artery's ostium while doing an aortogram.[6] Over the past few decades, advances in radiographic and catheter-based techniques have revolutionized left heart catheterization.
Left heart catheterization has diagnostic and therapeutic roles. Although it is used for assessing cardiac hemodynamics and valvular lesions, its primary diagnostic role is evaluating coronary artery disease. In the contemporary era, left heart catheterization, especially a selective coronary angiogram, is considered the gold standard for diagnosing coronary artery disease.[7] The therapeutic role of left heart catheterization has evolved extensively over the last 5 decades. Apart from percutaneous coronary intervention, left heart catheterization plays an essential role in the closure of congenital defects, radiofrequency ablation of arrhythmias, and valve replacement in the contemporary era.
Anatomy and Physiology
Register For Free And Read The Full Article
Search engine and full access to all medical articles
10 free questions in your specialty
Free CME/CE Activities
Free daily question in your email
Save favorite articles to your dashboard
Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Anatomy and Physiology
In the early era of catheterization, left heart catheterization was performed by cutting down the brachial and radial arteries, which are no longer used.[8] The current techniques involve percutaneous access to the radial or femoral arteries via needle puncture.[9] The radial artery is the terminal branch of the brachial artery; it runs on the lateral aspect of the forearm and supplies the posterolateral aspect of the forearm.[10] The femoral artery is the continuation of the external iliac artery and constitutes the lower limb's major blood supply.[11]
The radial artery is a branch of the brachial artery, which is a continuation of the axillary artery. The axillary artery is formed by the continuation of the subclavian artery when it crosses the first rib.[12] The common femoral artery is formed from a continuation of the external iliac artery when it crosses the inguinal ligament. The external iliac artery is the larger branch of the common iliac artery, and the common iliac artery originates as a result of the bifurcation of the abdominal aorta at the level of the fourth lumbar vertebra.[13] In the contemporary era—and now explicitly—radial access is recommended over femoral for coronary angiography/percutaneous coronary intervention in acute coronary syndrome to reduce bleeding, vascular complications, and mortality (Class I, 2025 American College of Cardiology/American Heart Association [ACC/AHA] guidelines for the management of patients with ACS).[14][15][16]
Indications
Left heart catheterization is used for diagnostic and therapeutic purposes with various indications.[17][18][19] These indications include:
- Evaluation and treatment of coronary artery disease
- Assessment and evaluation of coronary artery bypass grafts
- Evaluation and treatment of coronary artery disease in patients with chest pain of uncertain origin, when noninvasive tests are not diagnostic
- Assessment of the severity of valvular or myocardial disorders, such as aortic stenosis, aortic insufficiency, mitral stenosis, mitral insufficiency, and cardiomyopathies, to determine the need for surgical correction when there is a discrepancy between signs, symptoms, and echocardiographic findings
- Evaluation and treatment of cardiac arrhythmias
- Percutaneous closure of congenital cardiac defects such as atrial septal defect, ventricular septal defect, and patent ductus arteriosus
- Treatment of valvular heart diseases, such as valvuloplasty or percutaneous transcatheter valve replacement
- ACS timing and strategy (2025 update): In ST-elevation myocardial infarction (STEMI), perform emergent angiography/primary PCI with first medical contact (FMC)-to-device goal ≤90 minutes. In non-ST-elevation acute coronary syndrome (NSTE-ACS), pursue an immediate invasive strategy (140). Routine use of P2Y12 inhibitors (P2Y12), which are antiplatelet drugs, pretreatment before defining coronary anatomy is discouraged when an early invasive approach is planned.[14][15]
Contraindications
There are no absolute contraindications to left heart catheterization, except for the patient's refusal.
The relative contraindications may include:
- Severe uncontrolled hypertension
- Unstable arrhythmias
- Acute cerebrovascular accidents
- Active bleeding
- Allergy to radiographic contrast
- Renal dysfunction
- Acute pulmonary edema (patient unable to lie flat)
- Untreated active infection/sepsis
- Severe coagulopathy
- Encephalopathy
- Significant peripheral vascular disease
Depending on the risk-benefit analysis, the procedure can be considered in these situations. For elective cases, optimize severe uncontrolled hypertension consistent with the 2025 ACC/AHA High Blood Pressure Guideline before proceeding when feasible.[14]
Equipment
The following equipment is required for a left heart catheterization:
- Cardiac catheterization laboratory
- Fluoroscopy machine
- Hemodynamic monitors
- Different diagnostic and guide catheters
- Guide wires
- Manifold for contrast injection
- Coronary wires, balloons, and stents for PCI
Personnel
Left heart catheterization is a multidisciplinary procedure.[20] The following personnel are required to perform left heart catheterization:
- Cardiologist, having expertise in diagnostic and interventional cardiac catheterization
- Cardiovascular technologist to assist the cardiologist
- Cardiac catheterization nurse for the administration of drugs
- Anesthesiologist (for sedation support in high-risk cases)
Preparation
Oral anticoagulants are stopped at least 24 hours before the procedure (depending on the creatinine clearance).[21] Before the procedure, a thorough medical history should be taken, with special emphasis on any known allergies to contrast agents.[22] A detailed examination is done to assess the access site, and peripheral pulses are documented. Laboratory investigations, including hemoglobin, platelet count, creatinine, and coagulation profile, should be performed. The operating provider should obtain informed consent, and the procedure should be explained in detail, including its risks and complications. Intravenous normal saline should be administered to prevent contrast-induced renal dysfunction, especially in those with underlying renal dysfunction.[23]
After being transferred to the catheterization laboratory, the patient is placed in the supine position on the table, the access sites are sterilized, and the patient is draped. All cannulas, needles, and catheters are flushed with heparinized saline.[24] Cardiologists and assisting technologists wear a sterile gown, gloves, a head cap, and facial protective shields.
NSTE-ACS antiplatelet strategy (2025 update): If an early invasive approach is planned and coronary anatomy is unknown, avoid routine P2Y12 pretreatment; load once anatomy/strategy are defined (class III: no benefit for routine pretreatment). Pre-elective left heart catheterization blood pressure optimization should follow the 2025 ACC/AHA High Blood Pressure Guideline to mitigate periprocedural risk and facilitate safe radial access.[14]
Technique or Treatment
Arterial Access
For radial access, it is better to perform a Barbeau or Allen test to assess the adequacy of collateral circulation to the hand.[25] Then the arm is positioned by the side of the body on the board. To facilitate palpation and puncture of the radial artery, the wrist is hyperextended by keeping a roll under it. For left radial access, the puncture is performed with the arm hyperextended; after establishing access, the hand is positioned over the chest or left groin by supporting the elbow with a pillow. Before a radial puncture, patients are premedicated with midazolam, nalbuphine, or fentanyl to avoid radial spasm provoked by anxiety.[26] The ideal site of radial puncture is 2 to 3 cm above the wrist crease, where the artery is best palpable. The subsequent attempt should be at 1 cm proximal to the initial puncture site.[27]
After injecting local analgesics at the puncture site, the artery is punctured using a 20-gauge cannula by the Seldinger technique. After the initial blood blob is seen in the cannula's proximal hub, the needle is advanced to pierce the posterior wall, then removed. The cannula is withdrawn gradually while holding the straight-tipped hydrophilic Terumo wire in the right hand. Once the arterial blood spurts out, the wire is introduced into the radial artery, and the cannula is removed. An appropriately sized sheath with a hydrophilic coating is advanced over the wire, and the dilator is removed. Immediately after sheath insertion, blood pressure is monitored, and a combination of nitroglycerin (depending on systolic blood pressure) and 5000 international units of heparin is injected through the sheath to prevent radial spasm and minimize access-site complications.[28] Access strategy (2025 update): Adopt a radial-first approach for ACS angiography/PCI to reduce bleeding/vascular complications and mortality (class I).[14]
Anatomical landmarks for femoral access must be identified to ensure successful access and minimize complications at the access site. The femoral artery lies midway between the anterosuperior crest of the iliac bone and the pubic bone, and it runs parallel to the medial aspect of the femoral head. This artery descends almost vertically down toward the femur's adductor tubercle and ends at the adductor magnus muscle opening in the femoral triangle.[29] The common femoral artery is the ideal site for puncture, as it is covered by a femoral sheath that prevents the formation of a pseudoaneurysm. This artery is more prominent when it runs over the femoral heads, and that is the best site of femoral puncture, as it is easy to achieve hemostasis by compressing it over the femoral head.[30]
After identifying the landmarks, a local analgesic is injected at the puncture site; then, the femoral artery is punctured with an 18-gauge cannula by the modified Seldinger method. A curved glide wire is introduced once blood spurts out of the cannula. After introducing the wire, the cannula is removed, and an appropriately sized sheath/dilator is advanced over the wire; the dilator is then removed along with the wire. Immediately after insertion, the sheath is flushed with heparinized saline, and blood pressures are monitored.[31]
Coronary Angiogram
For diagnostic coronary angiograms, diagnostic catheters are advanced over a wire under fluoroscopic guidance. Once the catheter reaches the ascending aorta, the wire is removed, and the catheter is connected to the manifold. Pressures are then recorded. Left main and right coronary arteries are engaged in plain anteroposterior (AP) and left anterior oblique (LAO) projections, and multiple images are taken from different projections for each artery.[32]
For PCI, guide catheters are advanced over the wires. After engaging the appropriate coronary artery, coronary wires are advanced through the catheter, crossing the stenotic area. Once the wire has crossed the lesion, the lesion is either predilated with a balloon or directly stented with an appropriately sized stent, then post-dilated with an appropriately sized balloon.[33] Imaging (2025 update): Use of intracoronary imaging, intravascular ultrasound/optical coherence tomography (IVUS/OCT), to guide PCI in left main and other complex lesions is now class I in the ACS guideline (upgraded from prior class IIa), based on evidence demonstrating fewer stent-related and clinical events.[14]
Left Ventriculogram
The left ventriculogram provides an assessment of left ventricular systolic function, degree of mitral regurgitation, and the presence of wall motion abnormality or a VSD. A side hole (pigtail) catheter is advanced over a 0.035-in J-tipped wire to a position in the ascending aorta superior to the aortic valve. The tip is then pointed toward the valve orifice, and the catheter is rotated so that the pigtail loop resembles a "6." In this position, the catheter is gently advanced across the valve orifice into the ventricle.
After entering the ventricle, the pigtail's tip is positioned midcavity to avoid contact with the papillary muscles and mitral valve.[34] Once the pigtail is in position, 30 to 40 cc of contrast is injected through the pigtail catheter while recording cineangiography. The image is taken in the right anterior oblique projection to assess the anterior wall, inferior wall, and left ventricular apex. The left anterior oblique (cranial 20) projection is used to assess the septum and ventricular septal defects.[35]
Assessment of the Aortic Valve
With the advent of echocardiography and Doppler techniques, cardiac catheterization is no longer a commonly used diagnostic modality for assessing aortic stenosis. Instead, it is recommended when there is a discrepancy between the symptoms and echocardiographic findings. Pressure gradients across the aortic valve are measured with a double-lumen fluid-filled catheter.[36] Left ventricular and aortic pressures are measured simultaneously. Pullback gradients are inaccurate for diagnostic purposes.[37]
During any valvular assessment, right heart catheterization is commonly performed. During a right heart catheterization, pressures are measured in the right atrium, right ventricle, pulmonary artery, and the wedge position. Cardiac output can be measured using the Fick or thermodilution method.[38] The Fick method is based on arterial and mixed venous oxygen saturations, hemoglobin levels, and oxygen consumption. In the thermodilution method, cold or room-temperature saline is injected through the correct atrial port of the Swan-Ganz catheter, and a temperature change is measured at the thermistor.[39]
After measuring right-sided pressures and cardiac output, the effective orifice area is calculated using the Gorlin equation.[40] However, the area differs from the corresponding echocardiographic measurement due to the difficulty in precisely positioning the aortic-side catheter at the vena contracta of the flow jet. Aortic regurgitation (AR) severity can be assessed and graded with an aortic angiogram. This modality is reported to overestimate AR and not accurately evaluate it in the presence of left ventricular systolic dysfunction and other valvular lesions.[41]
Angiographic grading of aortic regurgitation may include:
- Mild (1+): A little contrast enters the left ventricle during diastole and clears with each systole.
- Moderate AR (2+): Contrast enters the left ventricle with each diastole, but the left ventricle is less dense than the aorta.
- Moderately severe AR (3+): The left ventricle has the same density as the ascending aorta.
- Severe AR (4+): Dense, complete, opacification of the left ventricle occurs on the first beat; it is more densely opacified than the ascending aorta.
Assessment of Mitral Valve
The gradient across the mitral valve is determined by measuring the left ventricular and left atrial pressures to assess the mitral stenosis. Although the pulmonary artery wedge pressure (PAWP) is typically used as a surrogate for left atrial pressure, the most accurate method involves measuring both left atrial and left ventricular pressures, which requires a transseptal catheterization approach.[42] The PAWP tracing is realigned with the left ventricular tracing to determine an accurate mean gradient.[43] The mitral regurgitation severity is based on the amount of contrast regurgitated from the left ventricle into the left atrium via an incompetent mitral valve and the opacification of the left atrium used as a guide.[44]
- Grade 1+ (mild): Regurgitation essentially clears with each beat and never opacifies the entire left atrium.
- Grade 2+ (moderate): Regurgitation does not clear with one beat and opacifies the entire left atrium after several beats.
- Grade 3+ (moderately severe): The left atrium is opacified completely and achieves equal opacification to the left ventricle.
- Grade 4+ (severe): The entire left atrium is opacified within one beat and becomes denser with each beat, with associated refluxing into the pulmonary veins during systole.
Complications
The incidence of major complications related to left heart catheterization is low, and the majority of the deaths occurring postprocedure are secondary to acute illness. The most common complications associated with left heart catheterization may include access site complications, contrast allergy, cerebrovascular accidents, myocardial infarction, pericardial effusion, cardiac tamponade, and aortic or coronary artery dissection.[45] Access site complications may include bleeding, hematoma formation, pseudoaneurysm, arteriovenous fistulae, perforation, and arterial dissection.[46][47] Although access-site complications are reported to be more common with the transfemoral than the transradial approach, advances in techniques, ultrasound use, and closure devices have significantly reduced their incidence.[48][49] The incidence of cerebrovascular accidents is less than 0.1% for a diagnostic left heart catheterization, and it is as high as 0.4% for percutaneous coronary intervention. Advanced age, hypertension, diabetes mellitus, prior cerebrovascular accidents, heart failure, aortic atherosclerosis, and emergency procedures are the risk factors for periprocedural stroke.[50]
Myocardial infarction during left heart catheterization is reported as 0.2 per 10,000 procedures, and coronary artery dissection causes myocardial infarction in almost all cases. The incidence of cardiac tamponade is reported as low as 0.009% for a diagnostic left heart catheterization.[45] Guideline-aligned radial-first access and routine imaging in complex ACS PCI are associated with lower bleeding/vascular and stent-related complications, respectively.[14]
Contrast-related complications include allergic reaction and contrast-induced renal dysfunction. Urticaria is the common manifestation of contrast-related allergy, and it can lead to anaphylaxis. Contrast-induced nephropathy is a serious complication of cardiac catheterization, and it is much more common in the presence of underlying renal dysfunction, heart failure, and left ventricular systolic dysfunction. Although there is no definite treatment for contrast-induced nephropathy, it can be prevented by minimizing the contrast volume and preventing volume depletion.[51]
Clinical Significance
Cardiac catheterization has evolved over the years, and it is often a life-saving procedure in acute myocardial infarction, where left-heart catheterization and selective coronary arteriography are performed in an emergency to identify the culprit vessel, and percutaneous coronary intervention is performed to preserve myocardium at risk. With new techniques and advances, the transradial approach offers greater patient comfort than the transfemoral approach. Using ultrasound/fluoroscopy to obtain arterial access, using small-sized catheters, and increasing operator experience have further reduced complications.
In the last 2 decades, percutaneous valve replacement has revolutionized the treatment of valvular heart disease. Measurements of cardiac hemodynamics obtained by left- and right-heart catheterization are essential for the diagnosis and prognosis of valvular heart disease and cardiomyopathies. The 2025 ACC/AHA ACS Guideline codifies practice-changing points relevant to LHC/PCI: radial-first access (class I), selective P2Y12 pretreatment strategy in NSTE-ACS, default 12-month dual antiplatelet therapy (DAPT) with tailoring for bleeding risk, and class I adoption of intravascular ultrasound/optical coherence tomography (IVUS/OCT) for complex/left main PCI. For elective cases, blood pressure optimization in line with the 2025 ACC/AHA High Blood Pressure Guideline supports safer access/antithrombotic decisions, as well as long-term prevention.[14][16]
Enhancing Healthcare Team Outcomes
Left heart catheterization requires a coordinated, multidisciplinary approach to optimize patient-centered care, safety, and outcomes. Advanced clinicians must possess strong procedural and diagnostic skills to evaluate coronary anatomy, ventricular function, and hemodynamics while integrating pre-procedure risk assessment, anticoagulation management, and postprocedure monitoring. Nurses play a pivotal role in patient preparation, continuous hemodynamic observation, and early identification of complications such as bleeding or arrhythmias. Pharmacists contribute by ensuring appropriate medication reconciliation, antiplatelet and anticoagulant management, and minimizing adverse drug interactions, particularly in patients with complex comorbidities.
Effective interprofessional communication and care coordination are essential throughout the peri-procedural continuum. Structured briefings, shared electronic documentation, and standardized handoffs ensure that all team members—clinicians, nurses, technologists, and pharmacists—are aligned on patient status and procedural plans. Collaborative decision-making supports rapid response to evolving clinical situations, reduces procedural complications, and enhances recovery. This cohesive teamwork fosters a culture of safety, improves patient satisfaction, and strengthens overall team performance by emphasizing accountability, transparency, and mutual respect within the cardiac care environment.
References
Ribatti D. William Harvey and the discovery of the circulation of the blood. Journal of angiogenesis research. 2009 Sep 21:1():3. doi: 10.1186/2040-2384-1-3. Epub 2009 Sep 21 [PubMed PMID: 19946411]
Hall WD. Stephen Hales: theologian, botanist, physiologist, discoverer of hemodynamics. Clinical cardiology. 1987 Aug:10(8):487-9 [PubMed PMID: 3304746]
Bourassa MG. The history of cardiac catheterization. The Canadian journal of cardiology. 2005 Oct:21(12):1011-4 [PubMed PMID: 16234881]
ZIMMERMAN HA, SCOTT RW, BECKER NO. Catheterization of the left side of the heart in man. Circulation. 1950 Mar:1(3):357-9 [PubMed PMID: 15405704]
Meruane J. [Historic perspective of cardiac catheterization]. Revista medica de Chile. 1992 Oct:120(10):1184-90 [PubMed PMID: 1341787]
Level 3 (low-level) evidenceRyan TJ. The coronary angiogram and its seminal contributions to cardiovascular medicine over five decades. Transactions of the American Clinical and Climatological Association. 2002:113():261-71 [PubMed PMID: 12053714]
Lim MJ, White CJ. Coronary angiography is the gold standard for patients with significant left ventricular dysfunction. Progress in cardiovascular diseases. 2013 Mar-Apr:55(5):504-8. doi: 10.1016/j.pcad.2013.01.003. Epub [PubMed PMID: 23518380]
Rao SV, Stone GW. Arterial access and arteriotomy site closure devices. Nature reviews. Cardiology. 2016 Nov:13(11):641-650. doi: 10.1038/nrcardio.2016.133. Epub 2016 Aug 25 [PubMed PMID: 27558003]
Sandoval Y, Burke MN, Lobo AS, Lips DL, Seto AH, Chavez I, Sorajja P, Abu-Fadel MS, Wang Y, Poulouse A, Gössl M, Mooney M, Traverse J, Tierney D, Brilakis ES. Contemporary Arterial Access in the Cardiac Catheterization Laboratory. JACC. Cardiovascular interventions. 2017 Nov 27:10(22):2233-2241. doi: 10.1016/j.jcin.2017.08.058. Epub [PubMed PMID: 29169493]
Marchese RM, Launico MV, Geiger Z. Anatomy, Shoulder and Upper Limb, Forearm Radial Artery. StatPearls. 2025 Jan:(): [PubMed PMID: 31536233]
Swift H, Bordoni B. Anatomy, Bony Pelvis and Lower Limb: Femoral Artery. StatPearls. 2025 Jan:(): [PubMed PMID: 30855850]
Brzezinski M, Luisetti T, London MJ. Radial artery cannulation: a comprehensive review of recent anatomic and physiologic investigations. Anesthesia and analgesia. 2009 Dec:109(6):1763-81. doi: 10.1213/ANE.0b013e3181bbd416. Epub [PubMed PMID: 19923502]
Yadav MK, Mohammed AKM, Puramadathil V, Geetha D, Unni M. Lower extremity arteries. Cardiovascular diagnosis and therapy. 2019 Aug:9(Suppl 1):S174-S182. doi: 10.21037/cdt.2019.07.08. Epub [PubMed PMID: 31559162]
Rao SV, O'Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH, Baber U, Baker H, Cohen MG, Cruz-Ruiz M, Davis LL, de Lemos JA, DeWald TA, Elgendy IY, Feldman DN, Goyal A, Isiadinso I, Menon V, Morrow DA, Mukherjee D, Platz E, Promes SB, Sandner S, Sandoval Y, Schunder R, Shah B, Stopyra JP, Talbot AW, Taub PR, Williams MS. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025 Apr:151(13):e771-e862. doi: 10.1161/CIR.0000000000001309. Epub 2025 Feb 27 [PubMed PMID: 40014670]
Level 1 (high-level) evidenceKumbhani DJ, Cibotti-Sun M, Moore MM. 2025 Acute Coronary Syndromes Guideline-at-a-Glance. Journal of the American College of Cardiology. 2025 Jun 10:85(22):2128-2134. doi: 10.1016/j.jacc.2025.01.018. Epub 2025 Feb 27 [PubMed PMID: 40013745]
Azizi M, Juraschek SP. A Trans-Atlantic Perspective on the 2025 AHA/ACC Guidelines for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Circulation. 2025 Sep 16:152(11):743-747. doi: 10.1161/CIRCULATIONAHA.125.075742. Epub 2025 Aug 14 [PubMed PMID: 40811494]
Level 3 (low-level) evidenceManda YR, Baradhi KM. Cardiac Catheterization Risks and Complications. StatPearls. 2025 Jan:(): [PubMed PMID: 30285356]
Patel MR, Bailey SR, Bonow RO, Chambers CE, Chan PS, Dehmer GJ, Kirtane AJ, Wann LS, Ward RP. ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. Journal of the American College of Cardiology. 2012 May 29:59(22):1995-2027. doi: 10.1016/j.jacc.2012.03.003. Epub 2012 May 9 [PubMed PMID: 22578925]
Sorajja P, Borlaug BA, Dimas VV, Fang JC, Forfia PR, Givertz MM, Kapur NK, Kern MJ, Naidu SS. SCAI/HFSA clinical expert consensus document on the use of invasive hemodynamics for the diagnosis and management of cardiovascular disease. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2017 Jun 1:89(7):E233-E247. doi: 10.1002/ccd.26888. Epub 2017 May 10 [PubMed PMID: 28489331]
Level 3 (low-level) evidenceNaidu SS, Aronow HD, Box LC, Duffy PL, Kolansky DM, Kupfer JM, Latif F, Mulukutla SR, Rao SV, Swaminathan RV, Blankenship JC. SCAI expert consensus statement: 2016 best practices in the cardiac catheterization laboratory: (Endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologia intervencionista; Affirmation of value by the Canadian Association of interventional cardiology-Association canadienne de cardiologie d'intervention). Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2016 Sep:88(3):407-23. doi: 10.1002/ccd.26551. Epub 2016 May 2 [PubMed PMID: 27137680]
Level 3 (low-level) evidenceBarnes GD, Mouland E. Peri-Procedural Management of Oral Anticoagulants in the DOAC Era. Progress in cardiovascular diseases. 2018 Mar-Apr:60(6):600-606. doi: 10.1016/j.pcad.2018.03.002. Epub 2018 Mar 10 [PubMed PMID: 29534986]
Bottinor W, Polkampally P, Jovin I. Adverse reactions to iodinated contrast media. The International journal of angiology : official publication of the International College of Angiology, Inc. 2013 Sep:22(3):149-54. doi: 10.1055/s-0033-1348885. Epub [PubMed PMID: 24436602]
Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, Marsch S, Roskamm H. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Archives of internal medicine. 2002 Feb 11:162(3):329-36 [PubMed PMID: 11822926]
Level 1 (high-level) evidenceZiyaeifard M, Alizadehasl A, Aghdaii N, Sadeghi A, Azarfarin R, Masoumi G, Golbargian G. Heparinized and Saline Solutions in the Maintenance of Arterial and Central Venous Catheters After Cardiac Surgery. Anesthesiology and pain medicine. 2015 Aug:5(4):e28056. doi: 10.5812/aapm28056. Epub 2015 Aug 22 [PubMed PMID: 26478866]
Barbeau GR, Arsenault F, Dugas L, Simard S, Larivière MM. Evaluation of the ulnopalmar arterial arches with pulse oximetry and plethysmography: comparison with the Allen's test in 1010 patients. American heart journal. 2004 Mar:147(3):489-93 [PubMed PMID: 14999199]
Kristić I, Lukenda J. Radial artery spasm during transradial coronary procedures. The Journal of invasive cardiology. 2011 Dec:23(12):527-31 [PubMed PMID: 22147403]
Chugh SK, Chugh Y, Chugh S. How to tackle complications in radial procedures: Tip and tricks. Indian heart journal. 2015 May-Jun:67(3):275-81. doi: 10.1016/j.ihj.2015.05.016. Epub 2015 Jun 16 [PubMed PMID: 26138190]
Chen CW, Lin CL, Lin TK, Lin CD. A simple and effective regimen for prevention of radial artery spasm during coronary catheterization. Cardiology. 2006:105(1):43-7 [PubMed PMID: 16254422]
Level 1 (high-level) evidenceSpector KS, Lawson WE. Optimizing safe femoral access during cardiac catheterization. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2001 Jun:53(2):209-12 [PubMed PMID: 11387606]
Spijkerboer AM, Scholten FG, Mali WP, van Schaik JP. Antegrade puncture of the femoral artery: morphologic study. Radiology. 1990 Jul:176(1):57-60 [PubMed PMID: 2353111]
Irani F, Kumar S, Colyer WR Jr. Common femoral artery access techniques: a review. Journal of cardiovascular medicine (Hagerstown, Md.). 2009 Jul:10(7):517-22. doi: 10.2459/JCM.0b013e32832a1e00. Epub [PubMed PMID: 19412124]
Di Mario C, Sutaria N. Coronary angiography in the angioplasty era: projections with a meaning. Heart (British Cardiac Society). 2005 Jul:91(7):968-76 [PubMed PMID: 15958378]
Ahmad M, Mehta P, Reddivari AKR, Mungee S. Percutaneous Coronary Intervention. StatPearls. 2025 Jan:(): [PubMed PMID: 32310583]
Aznaouridis K, Masoura C, Kastellanos S, Alahmar A. Inadvertent cardiac phlebography. World journal of cardiology. 2017 Jun 26:9(6):558-561. doi: 10.4330/wjc.v9.i6.558. Epub [PubMed PMID: 28706592]
Witteles RM, Knowles JW, Perez M, Morris WM, Spettell CM, Brennan TA, Heidenreich PA. Use and overuse of left ventriculography. American heart journal. 2012 Apr:163(4):617-23.e1. doi: 10.1016/j.ahj.2011.12.018. Epub 2012 Mar 29 [PubMed PMID: 22520528]
Level 2 (mid-level) evidencePibarot P, Dumesnil JG. Improving assessment of aortic stenosis. Journal of the American College of Cardiology. 2012 Jul 17:60(3):169-80. doi: 10.1016/j.jacc.2011.11.078. Epub [PubMed PMID: 22789881]
Brogan WC 3rd, Lange RA, Hillis LD. Accuracy of various methods of measuring the transvalvular pressure gradient in aortic stenosis. American heart journal. 1992 Apr:123(4 Pt 1):948-53 [PubMed PMID: 1550005]
Engoren M, Barbee D. Comparison of cardiac output determined by bioimpedance, thermodilution, and the Fick method. American journal of critical care : an official publication, American Association of Critical-Care Nurses. 2005 Jan:14(1):40-5 [PubMed PMID: 15608107]
Opotowsky AR, Hess E, Maron BA, Brittain EL, Barón AE, Maddox TM, Alshawabkeh LI, Wertheim BM, Xu M, Assad TR, Rich JD, Choudhary G, Tedford RJ. Thermodilution vs Estimated Fick Cardiac Output Measurement in Clinical Practice: An Analysis of Mortality From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program and Vanderbilt University. JAMA cardiology. 2017 Oct 1:2(10):1090-1099. doi: 10.1001/jamacardio.2017.2945. Epub [PubMed PMID: 28877293]
Level 3 (low-level) evidenceGORLIN R, GORLIN SG. Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. I. American heart journal. 1951 Jan:41(1):1-29 [PubMed PMID: 14799435]
Hunt D, Baxley WA, Kennedy JW, Judge TP, Williams JE, Dodge HT. Quantitative evaluation of cineaortography in the assessment of aortic regurgitation. The American journal of cardiology. 1973 Jun:31(6):696-700 [PubMed PMID: 4706726]
Bokhari SS, O'Neill WW, Cohen MG. A tale of two pressures: a case of pseudo-prosthetic mitral valve stenosis. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2011 Dec 1:78(7):1022-8. doi: 10.1002/ccd.22973. Epub 2011 Jul 21 [PubMed PMID: 22106062]
Level 3 (low-level) evidenceHall RJ, Kadushi OA, Evemy K. Need for cardiac catheterisation in assessment of patients for valve surgery. British heart journal. 1983 Mar:49(3):268-75 [PubMed PMID: 6830662]
Buckley RS, Kaul S, Jayaweera AR, Gimple LW, Powers ER, Dent JM. Quantification of mitral regurgitation in the cardiac catheterization laboratory with contrast echocardiography. American heart journal. 2000 Jun:139(6):1109-13 [PubMed PMID: 10827395]
Al-Hijji MA, Lennon RJ, Gulati R, El Sabbagh A, Park JY, Crusan D, Kanwar A, Behfar A, Lerman A, Holmes DR, Bell M, Singh M. Safety and Risk of Major Complications With Diagnostic Cardiac Catheterization. Circulation. Cardiovascular interventions. 2019 Jul:12(7):e007791. doi: 10.1161/CIRCINTERVENTIONS.119.007791. Epub 2019 Jul 9 [PubMed PMID: 31284736]
Wu PJ, Dai YT, Kao HL, Chang CH, Lou MF. Access site complications following transfemoral coronary procedures: comparison between traditional compression and angioseal vascular closure devices for haemostasis. BMC cardiovascular disorders. 2015 May 9:15():34. doi: 10.1186/s12872-015-0022-4. Epub 2015 May 9 [PubMed PMID: 25956814]
Coghill EM, Johnson T, Morris RE, Megson IL, Leslie SJ. Radial artery access site complications during cardiac procedures, clinical implications and potential solutions: The role of nitric oxide. World journal of cardiology. 2020 Jan 26:12(1):26-34. doi: 10.4330/wjc.v12.i1.26. Epub [PubMed PMID: 31984125]
Anjum I, Khan MA, Aadil M, Faraz A, Farooqui M, Hashmi A. Transradial vs. Transfemoral Approach in Cardiac Catheterization: A Literature Review. Cureus. 2017 Jun 3:9(6):e1309. doi: 10.7759/cureus.1309. Epub 2017 Jun 3 [PubMed PMID: 28690943]
Nguyen P, Makris A, Hennessy A, Jayanti S, Wang A, Park K, Chen V, Nguyen T, Lo S, Xuan W, Leung M, Juergens C. Standard versus ultrasound-guided radial and femoral access in coronary angiography and intervention (SURF): a randomised controlled trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2019 Aug 9:15(6):e522-e530. doi: 10.4244/EIJ-D-19-00336. Epub 2019 Aug 9 [PubMed PMID: 31113763]
Level 1 (high-level) evidenceWerner N, Zahn R, Zeymer U. Stroke in patients undergoing coronary angiography and percutaneous coronary intervention: incidence, predictors, outcome and therapeutic options. Expert review of cardiovascular therapy. 2012 Oct:10(10):1297-305. doi: 10.1586/erc.12.78. Epub [PubMed PMID: 23190068]
Mohammed NM, Mahfouz A, Achkar K, Rafie IM, Hajar R. Contrast-induced Nephropathy. Heart views : the official journal of the Gulf Heart Association. 2013 Jul:14(3):106-16. doi: 10.4103/1995-705X.125926. Epub [PubMed PMID: 24696755]